0001127602-22-014444.txt : 20220513
0001127602-22-014444.hdr.sgml : 20220513
20220513164122
ACCESSION NUMBER: 0001127602-22-014444
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220511
FILED AS OF DATE: 20220513
DATE AS OF CHANGE: 20220513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: REESE C RICHARD
CENTRAL INDEX KEY: 0001032365
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15943
FILM NUMBER: 22923471
MAIL ADDRESS:
STREET 1: C/O IRON MOUNTAIN INC
STREET 2: 745 ATLANTIC AVE 10TH FLR
CITY: BOSTON
STATE: MA
ZIP: 02111
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CENTRAL INDEX KEY: 0001100682
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 061397316
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 251 BALLARDVALE ST
CITY: WILMINGTON
STATE: MA
ZIP: 01887
BUSINESS PHONE: 781-222-6000
MAIL ADDRESS:
STREET 1: 251 BALLARDVALE ST
CITY: WILMINGTON
STATE: MA
ZIP: 01887
FORMER COMPANY:
FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL INC
DATE OF NAME CHANGE: 20000605
FORMER COMPANY:
FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES HOLDINGS INC
DATE OF NAME CHANGE: 19991208
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-05-11
0001100682
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CRL
0001032365
REESE C RICHARD
251 BALLARDVALE STREET
WILMINGTON
MA
01887
1
Common Stock
2022-05-11
4
A
0
575
0
A
64053
D
Common Stock
2022-05-11
4
A
0
382
0
A
64435
D
Stock Options (Right to Buy)
222.31
2022-05-11
4
A
0
1582
222.31
A
2023-05-11
2032-05-11
Common Stock
1582
1582
D
The unvested restricted stock units vest upon the earlier of 5/11/2023 or the business day prior to the Company's next annual meeting of shareholders.
The grant was made in lieu of director service fees for the term commencing May 10, 2022. The restricted stock units vest upon the earlier of 5/11/2023, or the business day prior to the Company's next annual meeting of shareholders.
The Stock Options become exercisable upon the earlier of 5/11/2023 or the business day prior to the Company's next annual meeting of shareholders.
/s/ C. Richard Reese
2022-05-13